Tech Company Financing Transactions

Clover Biopharmaceuticals Funding Round

Clover Biopharmaceuticals closed a $24 million Series B funding round on 6/9/2020. Backers included GL Ventures.

Transaction Overview

Announced On
6/9/2020
Transaction Type
Venture Equity
Amount
$24,000,000
Round
Series B
Investors
Proceeds Purpose
The funding will allow us to continue our efforts in expanding internal R&D capabilities and building a world-class team.

Company Information

Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
Building 1 Incubation Park Chengdu Hi-Tech Zone No. 1480 Nor B5-19
Chengdu Sichuan, 610041
China
Email Address
Overview
Founded by a team of world-class scientists returning to China, Clover Biopharmaceuticals is passionate about developing transformative biologic therapies for the millions of Chinese patients who currently do not have access to modern biological medicines.
Profile
Clover Biopharmaceuticals LinkedIn Company Profile
Social Media
Clover Biopharmaceuticals Company Twitter Account
Company News
Clover Biopharmaceuticals News
Facebook
Clover Biopharmaceuticals on Facebook
YouTube
Clover Biopharmaceuticals on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Joshua Liang
  Joshua Liang LinkedIn Profile  Joshua Liang Twitter Account  Joshua Liang News  Joshua Liang on Facebook
Chief Financial Officer
Phillip Lee
  Phillip Lee LinkedIn Profile  Phillip Lee Twitter Account  Phillip Lee News  Phillip Lee on Facebook
Chief Medical Officer
Philippe Bishop
  Philippe Bishop LinkedIn Profile  Philippe Bishop Twitter Account  Philippe Bishop News  Philippe Bishop on Facebook
Chief Medical Officer
Htay Han
  Htay Han LinkedIn Profile  Htay Han Twitter Account  Htay Han News  Htay Han on Facebook
Chief Scientific Officer
Peng Liang
  Peng Liang LinkedIn Profile  Peng Liang Twitter Account  Peng Liang News  Peng Liang on Facebook
Chief Technical Officer
David He
  David He LinkedIn Profile  David He Twitter Account  David He News  David He on Facebook
Executive Vice President
Min Dong
  Min Dong LinkedIn Profile  Min Dong Twitter Account  Min Dong News  Min Dong on Facebook
Vice President
Andrew Baker
  Andrew Baker LinkedIn Profile  Andrew Baker Twitter Account  Andrew Baker News  Andrew Baker on Facebook
Vice President
Ping Li
  Ping Li LinkedIn Profile  Ping Li Twitter Account  Ping Li News  Ping Li on Facebook
Vice President
Igor Smolenov
  Igor Smolenov LinkedIn Profile  Igor Smolenov Twitter Account  Igor Smolenov News  Igor Smolenov on Facebook
Vice President
Chris Wallace
  Chris Wallace LinkedIn Profile  Chris Wallace Twitter Account  Chris Wallace News  Chris Wallace on Facebook
VP - Bus. Development
Steven Gong
  Steven Gong LinkedIn Profile  Steven Gong Twitter Account  Steven Gong News  Steven Gong on Facebook
VP - Manufacturing
Andrew Chin
  Andrew Chin LinkedIn Profile  Andrew Chin Twitter Account  Andrew Chin News  Andrew Chin on Facebook
VP - Operations
Vincent Mwangi
  Vincent Mwangi LinkedIn Profile  Vincent Mwangi Twitter Account  Vincent Mwangi News  Vincent Mwangi on Facebook
VP - Product Management
Xiaobing Li
  Xiaobing Li LinkedIn Profile  Xiaobing Li Twitter Account  Xiaobing Li News  Xiaobing Li on Facebook
VP - Regulatory Affairs
Cindy Min
  Cindy Min LinkedIn Profile  Cindy Min Twitter Account  Cindy Min News  Cindy Min on Facebook
VP - Regulatory Affairs
Jian Ren
  Jian Ren LinkedIn Profile  Jian Ren Twitter Account  Jian Ren News  Jian Ren on Facebook


 

 

Browse more venture capital transactions:

Prev: 6/9/2020: ClassTag venture capital transaction
Next: 6/9/2020: HistoSonics venture capital transaction

 

Share this article

 


Where The Data Comes From

We do our best to report on every notable VC transaction. VC transactions reported here come from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary